R. Dahan

发表

FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis.

A. Korman, J. Ravetch, M. Selby, 2015, Cancer cell.

Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting

I. Amit, A. Weiner, T. Feferman, 2022, Nature Cancer.

Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity

J. Ravetch, R. Dahan, D. Knorr, 2018, Proceedings of the National Academy of Sciences.

Co-targeting of Adenosine Signaling Pathways for Immunotherapy: Potentiation by Fc Receptor Engagement.

J. Ravetch, R. Dahan, 2016, Cancer cell.

Type I and type II Fc receptors regulate innate and adaptive immunity

J. Ravetch, Jad Maamary, Andrew Pincetic, 2014, Nature Immunology.

Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis

B. Javid, N. Freund, J. Rybniker, 2021, Nature Communications.

BCR affinity differentially regulates colonization of the subepithelial dome and infiltration into germinal centers within Peyer’s patches

G. Yaari, M. Bemark, Ziv Shulman, 2019, Nature Immunology.

Therapeutic antibody activation of the glucocorticoid-induced TNF receptor by a clustering mechanism

J. Wolchok, J. Meyerson, T. Merghoub, 2022, Science advances.

Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens.

C. Katlama, E. Caumes, M. Gentilini, 1992, Journal of acquired immune deficiency syndromes.

Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.

A. Preisinger, J. Gebe, E. James, 2013, Journal of autoimmunity.

Therapeutic antibody activation of the glucocorticoid-induced TNF receptor by a clustering mechanism

J. Wolchok, J. Meyerson, T. Merghoub, 2022, Science advances.

HLA‐DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes

A. Vandenbark, H. Offner, C. David, 2004, Journal of neuroscience research.

Artificial Antigen Presenting Cells for Detection and Desensitization of Autoreactive T cells Associated with Type 1 Diabetes

M. Peakman, R. Chandrawati, Y. Reiter, 2022, Nano letters.

Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy

R. Dahan, Ran Salomon, 2022, Frontiers in Immunology.

Artificial Antigen Presenting Cells for Detection and Desensitisation of Auto-reactive T cells Associated with Type 1 Diabetes

M. Stevens, Michael Loran Dustin, M. Peakman, 2019, bioRxiv.

Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide).

J. Fiet, P. Grise, R. Dahan, 1989, The New England journal of medicine.

Unified platform for genetic and serological detection of COVID-19 with single-molecule technology

Eyal Sela, Adina Weinberger, Noa Furth, 2021, PLoS ONE.

Unified platform for genetic and serological detection of COVID-19 with single-molecule technology

Alexander M Schrager, A. Weinberger, D. Douek, 2021, medRxiv.

Unified platform for genetic and serological detection of COVID-19 with single-molecule technology

Eyal Sela, Adina Weinberger, Noa Furth, 2021, medRxiv.

Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis.

M. Rantalainen, C. Rolny, J. Fuxe, 2016, Cell reports.

Signaling by Antibodies: Recent Progress.

J. Ravetch, Jad Maamary, Taia T. Wang, 2017, Annual review of immunology.

HLA-DRα1 Constructs Block CD74 Expression and MIF Effects in Experimental Autoimmune Encephalomyelitis

R. Bucala, Xiaolin Yu, A. Vandenbark, 2014, The Journal of Immunology.

HLA-DRa1 Constructs Block CD74 Expression and MIF Effects in Experimental Autoimmune Encephalomyelitis

R. Bucala, Xiaolin Yu, A. Vandenbark, 2014 .

This information is current as Autoimmune Encephalomyelitis Expression and MIF Effects in Experimental 1 Constructs Block CD 74 α HLA-DR

R. Bucala, Xiaolin Yu, A. Vandenbark, 2014 .

Autoimmune Encephalomyelitis Expression and MIF Effects in Experimental 1 Constructs Block CD74 α HLA-DR

R. Bucala, Xiaolin Yu, A. Vandenbark, 2014 .

TCR‐like antibodies distinguish conformational and functional differences in two‐ versus four‐domain auto reactive MHC class II–peptide complexes

Shayne F. Andrew, A. Vandenbark, H. Offner, 2011, European journal of immunology.

Single-cell genomic approaches for developing the next generation of immunotherapies

Ido Amit, Ido Yofe, Rony Dahan, 2020, Nature Medicine.

FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis.

A. Korman, J. Ravetch, M. Selby, 2015, Cancer cell.

Single-cell genomic approaches for developing the next generation of immunotherapies

I. Amit, Ido Yofe, R. Dahan, 2020, Nature Medicine.

Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors

Nicolai J. Birkbak, Angela E. Leek, R. Booton, 2017, Immunity.

Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis.

M. Rantalainen, C. Rolny, J. Fuxe, 2016, Cell reports.

T-cell-receptor-like antibodies – generation, function and applications

Y. Reiter, R. Dahan, 2012, Expert Reviews in Molecular Medicine.

Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement.

Rony Dahan, A. Yamniuk, A. Korman, 2016, Cancer cell.

Immunity Report Fc-Optimized Anti-CD 25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors

M. Gore, C. Swanton, B. Challacombe, 2017 .

Fc g Rs Modulate the Anti-t umor Activity of Antibodies Targeting the PD-1 / PD-L 1 Axis Graphical Abstract Highlights

John, J. Ravetch, M. Selby, 2015 .

Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy

I. Amit, A. Alva, T. Feferman, 2023, Science Immunology.

FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies

B. Fox, B. Piening, C. Bifulco, 2023, bioRxiv.

Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern

Y. Levin, D. Shouval, T. Feferman, 2021, Cell Reports.

A Promising Therapeutic Approach for Multiple Sclerosis: Recombinant T-Cell Receptor Ligands Modulate Experimental Autoimmune Encephalomyelitis by Reducing Interleukin-17 Production and Inhibiting Migration of Encephalitogenic Cells into the CNS

M. Grafe, A. Vandenbark, H. Offner, 2007, The Journal of Neuroscience.

A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance.

Shayne F. Andrew, A. Vandenbark, H. Offner, 2013, Journal of Autoimmunity.

BCR affinity differentially regulates colonization of the subepithelial dome and infiltration into germinal centers within Peyer’s patches

G. Yaari, M. Bemark, Ziv Shulman, 2019, Nature Immunology.

T-cell-receptor-like antibodies – generation, function and applications

Y. Reiter, R. Dahan, 2012, Expert Reviews in Molecular Medicine.

Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols.

I. Amit, A. Tanay, Diego Jaitin, 2024, Nature cancer.

Bispecific dendritic-T cell engager potentiates anti-tumor immunity

I. Amit, A. Tanay, Z. Porat, 2024, Cell.

FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment

C. Bifulco, J. Ravetch, S. Jensen, 2023, Cancer immunology research.